Viridian Therapeutics, Inc.DE (VRDN)

Historical Portfolio Holders from 2020 to 2024

All holders as of
Q1 2024
Type / Class
Equity / COM
Shares, Excl. Options Q1 2024
$69.7M
Holdings value Q1 2024
$1.22B
Value change Q1 2024
+$173M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
143
Number of Buys Q1 2024
77
Number of Sells Q1 2024
-51
Average Buys Q1 2024 %
+0.002%
Average Sells Q1 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Filings
Period Shares, Excl. Options Value, Excl. Options Change Price Filings
2024 Q1 69.7M $1.22B +$173M $17.51 134
2023 Q4 59.6M $1.3B +$175M $21.78 138
2023 Q3 50.2M $770M +$30.5M $15.34 126
2023 Q2 47.1M $1.12B +$155M $23.79 139
2023 Q1 42.8M $1.09B +$90.8M $25.44 144
2022 Q4 40.9M $1.19B +$105M $29.21 124
2022 Q3 37.7M $774M +$232M $20.51 105
2022 Q2 28.2M $327M +$59.1M $11.57 81
2022 Q1 24.9M $461M +$27.1M $18.49 73
2021 Q4 23.3M $460M +$138M $19.77 54
2021 Q3 13.6M $223M +$137M $16.45 39
2021 Q2 6M $110M +$30.2M $18.29 24
2021 Q1 5.06M $84.5M +$80.7M $16.71 28
2020 Q4 229K $3.77M +$3.77M $16.46 2